The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study.
S Y BroeckxA M MartensA L BertoneL Van BrantegemL DuchateauLore L Van HeckeM DumoulinMaarten OosterlinckK ChiersH HusseinF PilleJ H SpaasPublished in: Equine veterinary journal (2019)
Equine allogeneic chondrogenic-induced mesenchymal stem cells combined with equine allogeneic plasma may be a promising treatment for osteoarthritis in horses. The Summary is available in Spanish - see Supporting Information.
Keyphrases
- mesenchymal stem cells
- bone marrow
- umbilical cord
- stem cell transplantation
- placebo controlled
- rheumatoid arthritis
- high glucose
- clinical trial
- open label
- study protocol
- knee osteoarthritis
- healthcare
- squamous cell carcinoma
- drug induced
- stem cells
- oxidative stress
- hematopoietic stem cell
- combination therapy
- endothelial cells
- phase ii